Tolvaptan
Ended Awarded
- Contract number
- 36C25220F0356
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,102
Award facts
- Contract value 100% obligated
- $10,102.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $10,102.19 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Tolvaptan on July 9, 2020, with a completion date of July 31, 2020. The delivery order was issued under the company's existing Blanket Purchase Agreement on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Tolvaptan, marketed as Jynarque, is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. No set-aside designation was applied to this award, reflecting the vendor's status as an established large pharmaceutical manufacturer. The goods were to be delivered to Pittsburgh, Pennsylvania.
This delivery order represents one of multiple task orders issued to Otsuka America Pharmaceutical Inc. under its substantial Indefinite Delivery Vehicle with the VA, which includes an $83.3 million Blanket Purchase Agreement for Jynarque and a $396 million Federal Supply Schedule contract for pharmaceutical and hematology-related products. The company's federal contract portfolio demonstrates its critical role in supplying specialized pharmaceutical treatments to the VA's Veterans Health Administration across multiple integrated service networks nationwide. These agreements streamline procurement of essential medications while ensuring veterans have access to complex treatment options for serious medical conditions.
Quick answers
Who was awarded contract 36C25220F0356?
36C25220F0356 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 9, 2020.
How much is contract 36C25220F0356 worth?
The government has obligated $10,102 on 36C25220F0356.
Is contract 36C25220F0356 an order under another contract?
Yes. 36C25220F0356 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25220F0356 competed?
The extent of competition for 36C25220F0356 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award